CXT Crane NXT, Co. Common Stock

NYSE · Electrical Equipment · Wyświetl na SEC EDGAR ↗

$52,50

Cena · Lip 2, 2026

Dane fundamentalne na dzień Maj 6, 2026

CXT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena

$52.50

Kapitalizacja Rynkowa

$2.70B

P/E (TTM)

18.8

EPS (TTM)

$2.50

Przychody (TTM)

$1.66B

Stopa dywidendy

1.4%

ROE

12.5%

D/E Dług/Kapitał

0.1

Zakres 52 tyg.

$36 – $69

CXT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $1.66B

2016-12-31 → 2025-12-31

EPS $2.50

2016-12-31 → 2025-12-31

Wolny przepływ pieniężny $198M

2016-12-31 → 2025-12-31

Marże 8.8%

2016-12-31 → 2021-12-31

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

P/E (TTM)

18.8

83.0

P/S (TTM)

1.6

8.2

P/B

2.2

5.2

EV / EBITDA

7.4

—

Price / FCF (Cena / FCF)

13.6

—

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

Operating Margin (Marża Operacyjna)

14.9%

—

Net Profit Margin (Marża Zysku Netto)

8.8%

1.3%

ROA

5.3%

1.3%

ROE

12.5%

7.4%

ROIC

14.2%

—

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

Debt / Equity (Dług / Kapitał Własny)

0.1

3.8

Current Ratio (Wskaźnik bieżący)

1.5

2.4

Quick Ratio (Wskaźnik Szybkości)

1.0

—

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

Revenue YoY (Przychody R/R)

11.4%

—

Revenue CAGR 3Y (Przychody CAGR 3L)

7.3%

—

Revenue CAGR 5Y (Przychody CAGR 5L)

-10.8%

—

EPS YoY

-21.6%

—

Net Income YoY (Zysk Netto R/R)

-21.2%

—

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

EPS (Diluted) (EPS (Rozwodniony))

$2.50

—

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik

Trend 5-letni

CXT

Mediana porównawcza

Payout Ratio (Wskaźnik Wypłaty Dywidendy)

26.9%

—

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

Stopa Dywidendy

1.4%

Wskaźnik Wypłaty Dywidendy

26.9%

CAGR dywidendy 5-letni

—

Data ex-dywidendy	Kwota
29 maja 2026	$0,1800
27 lutego 2026	$0,1800
28 listopada 2025	$0,1700
29 sierpnia 2025	$0,1700
30 maja 2025	$0,1700
28 lutego 2025	$0,1700
29 listopada 2024	$0,1600
30 sierpnia 2024	$0,1600
31 maja 2024	$0,1600
28 lutego 2024	$0,1600
29 listopada 2023	$0,1400
30 sierpnia 2023	$0,1400
30 maja 2023	$0,1400
27 lutego 2023	$0,1633
29 listopada 2022	$0,1633
30 sierpnia 2022	$0,1633
27 maja 2022	$0,1633
25 lutego 2022	$0,1633
29 listopada 2021	$0,1494
30 sierpnia 2021	$0,1494

CXT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 11 analityków

Mocne kupno 4 36,4%
Kup 5 45,5%
Trzymaj 2 18,2%
Sprzedaj 0 0,0%
Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

6 analityków · 2026-07-02

Mediana $66.00

Teraz $52.50

Niski $50.00

Wysoki $85.00

Średni cel $66.00 +25,7%

Średnia cel $66.83 +27,3%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie

0.01%

Następny raport

Sie 04, 2026

Okres	EPS Actual	EPS Szacowany	Niespodzianka
31 marca 2026	$0.60	$0.58	0.02%
31 grudnia 2025	$1.27	$1.27	0.00%
30 września 2025	$1.28	$1.28	0.00%
30 czerwca 2025	$0.97	$0.96	0.01%
31 marca 2025	$0.54	$0.52	0.02%

Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker	Kapitalizacja Rynkowa	P/E	Przychody r/r	Marża Netto	ROE	Marża brutto
CXT	$2.70B	18.8	11.4%	8.8%	12.5%	—
VNT	$5.29B	13.5	3.2%	13.2%	35.4%	—
OUST	$1.32B	-20.2	52.5%	-35.6%	-25.0%	49.3%
LASR	$1.92B	-79.8	31.6%	-9.0%	-10.6%	29.8%
ITRI	$4.17B	14.3	-3.0%	12.7%	19.4%	37.7%
OSIS	$3.78B	25.8	11.3%	8.7%	16.8%	34.3%
VPG	—	96.2	0.22%	1.7%	1.6%	38.9%
AEVA	$818M	-5.2	99.4%	-804.4%	277.1%	-3.6%
ARLO	$1.47B	99.9	3.6%	2.8%	12.1%	44.0%
NSSC	$1.06B	24.9	-3.8%	23.9%	25.3%	55.6%
EVLV	—	—	—	—	—	—

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 18

Dane roczne Rachunek zysków i strat dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$1.66B	$1.49B	$1.39B	$1.34B	$1.35B	$2.94B	$3.07B	$3.35B	$2.79B	$2.75B	$2.74B	$2.92B
Cost of Revenue	$953M	$822M	$737M	$714M	$746M	$1.93B	$1.94B	$2.16B	$1.77B	$1.76B	$1.79B	$1.91B
Gross Profit	·	·	·	·	$1.24B	$965M	$1.18B	$1.19B	$1.02B	$990M	$954M	$1.02B
R&D Expense	$46M	$40M	$43M	$34M	$33M	$75M	$74M	$89M	$58M	$62M	$63M	$68M
SG&A Expense	$440M	$386M	$367M	$319M	$323M	$698M	$679M	$712M	$606M	$611M	$566M	$605M
Operating Expenses	·	·	·	·	·	·	·	$2.90B	$2.40B	$2.56B	$2.37B	$2.61B
Operating Income	$247M	$269M	$287M	$301M	$279M	$263M	$183M	$441M	$388M	$187M	$373M	$316M
Interest Expense	·	·	·	$52M	$47M	$55M	$47M	$51M	$36M	$36M	$38M	$39M
Interest Income	$1M	$2M	$1M	$200.0K	$100.0K	$2M	$3M	$2M	$2M	$2M	$2M	$2M
Other Non-op	$5M	$3M	$2M	$3M	$5M	$15M	$5M	$19M	$13M	$12M	$-700.0K	$2M
Pretax Income	$181M	$226M	$240M	$248M	$226M	$224M	$144M	$411M	$368M	$164M	$336M	$281M
Income Tax	$36M	$42M	$52M	$43M	$48M	$43M	$31M	$76M	$195M	$40M	$106M	$88M
Net Income	$145M	$184M	$188M	$205M	$178M	$181M	$133M	$336M	$172M	$123M	$229M	$193M
EPS (Basic)	$2.53	$3.22	$3.31	$3.61	$3.14	$3.10	$2.23	$5.63	$2.89	$2.10	$3.94	$3.28
EPS (Diluted)	$2.50	$3.19	$3.28	$3.61	$3.14	$3.08	$2.20	$5.50	$2.84	$2.07	$3.89	$3.23
Shares (Basic)	57,400,000	57,100,000	56,800,000	56,700,000	56,700,000	58,300,000	59,800,000	59,600,000	59,400,000	58,500,000	58,100,000	58,700,000
Shares (Diluted)	58,000,000	57,800,000	57,500,000	56,700,000	56,700,000	58,800,000	60,600,000	61,000,000	60,400,000	59,300,000	58,800,000	59,600,000
EBITDA	$353M	$356M	$364M	$488M	$622M	$390M	$324M	$561M	$475M	$268M	$440M	$392M

Bilans 30

Dane roczne Bilans dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$234M	$166M	$227M	$231M	$479M	$551M	$394M	$343M	$706M	$510M	$364M	$364M
Receivables	$352M	$266M	$215M	$205M	$483M	$424M	$555M	$516M	$418M	$396M	$398M	$411M
Inventory	$170M	$145M	$157M	$146M	$449M	$430M	$457M	$412M	$349M	$342M	$377M	$370M
Other Current Assets	$85M	$57M	$45M	$42M	$119M	$137M	$80M	$76M	$20M	$20M	$18M	$15M
Current Assets	$853M	$642M	$644M	$623M	$1.54B	$1.57B	$1.50B	$1.36B	$1.52B	$1.32B	$1.20B	$1.20B
PP&E (Net)	$304M	$272M	$261M	$262M	$556M	$574M	$616M	$599M	$282M	$279M	$276M	$290M
PP&E (Gross)	$689M	$600M	$564M	$522M	$1.29B	$1.19B	$1.26B	$1.19B	$839M	$827M	$810M	$825M
Accum. Depreciation	$385M	$328M	$303M	$260M	$733M	$618M	$641M	$586M	$557M	$548M	$534M	$535M
Goodwill	$1.16B	$957M	$841M	$837M	$861M	$1.61B	$1.30B	$1.40B	$1.21B	$1.21B	$1.17B	$1.19B
Intangibles	$557M	$419M	$309M	$345M	$388M	$433M	$505M	$478M	$277M	$282M	$317M	$354M
Other Non-current Assets	$97M	$92M	$71M	$57M	$259M	$197M	$211M	$101M	$115M	$95M	$101M	$98M
Total Assets	$3.12B	$2.39B	$2.13B	$2.13B	$4.49B	$4.62B	$4.42B	$4.04B	$3.59B	$3.43B	$3.34B	$3.45B
Accounts Payable	$132M	$117M	$106M	$110M	$274M	$199M	$311M	$329M	$247M	$223M	$223M	$229M
Accrued Liabilities	$273M	$211M	$210M	$204M	$443M	$388M	$378M	$337M	$252M	$223M	$219M	$226M
Short-term Debt	$135M	$210M	$5M	$300M	$0	$376M	$149M	$7M	$249M	$0	$50M	$101M
Current Liabilities	$569M	$562M	$334M	$631M	$789M	$1.06B	$917M	$740M	$838M	$521M	$573M	$640M
Capital Leases	$56M	$53M	$43M	$29M	$79M	$86M	$92M	·	·	·	·	·
Deferred Tax	$151M	$119M	$104M	$110M	$77M	$54M	$56M	$53M	$45M	$42M	$50M	$46M
Other Non-current Liabilities	$116M	$80M	$64M	$38M	$161M	$171M	$188M	$85M	$108M	$100M	$113M	$132M
Total Liabilities	$1.86B	$1.32B	$1.17B	$1.35B	$2.65B	$3.08B	$2.95B	$2.52B	$2.25B	$2.28B	$2.19B	$2.38B
Long-term Debt	$1.00B	$541M	$640M	$545M	$842M	$843M	$842M	$949M	·	·	·	·
Total Debt	$135M	$210M	$5M	$1.24B	$842M	$1.22B	$991M	$949M	$744M	$745M	$799M	$850M
Common Stock	$72M	$72M	$72M	$0	$72M	$72M	$72M	$72M	$72M	$72M	$72M	$72M
Paid-in Capital	$1.72B	$1.72B	$1.73B	$0	$364M	$331M	$316M	$304M	$292M	$277M	$264M	$249M
Retained Earnings	$374M	$268M	$121M	$0	$2.53B	$2.19B	$2.11B	$2.07B	$1.81B	$1.72B	$1.67B	$1.52B
Treasury Stock	$810M	$823M	$839M	$0	$691M	$601M	$543M	$476M	$452M	$459M	$494M	$485M
AOCI	$-100M	$-173M	$-119M	$-132M	$-440M	$-466M	$-484M	$-448M	$-380M	$-476M	$-377M	$-299M
Stockholders' Equity	$1.25B	$1.06B	$964M	$784M	$764M	$914M	$1.47B	$1.52B	$1.35B	$1.13B	$1.14B	$1.06B
Liabilities + Equity	$3.12B	$2.39B	$2.13B	$2.13B	$4.49B	$4.62B	$4.42B	$4.04B	$3.59B	$3.43B	$3.34B	$3.45B
Shares Outstanding	57,441,541	57,197,147	56,897,457	56,325,382	57,835,865	58,127,948	59,002,205	59,508,401	59,411,636	58,964,859	58,109,037	58,185,267

Przepływy pieniężne 19

Dane roczne Przepływy pieniężne dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$107M	$87M	$78M	$79M	$82M	$128M	$108M	$120M	$73M	$67M	$67M	$76M
Stock-based Comp	$13M	$11M	$10M	$9M	$9M	$22M	$22M	$22M	$22M	$22M	$21M	$21M
Deferred Tax	$-14M	$-15M	$-2M	$-28M	$8M	$18M	$-28M	$48M	$102M	$-25M	$40M	$38M
Amort. of Intangibles	$60M	$47M	$36M	$36M	$37M	$48M	$38M	$44M	$31M	$31M	$32M	$38M
Restructuring	$17M	$10M	$500.0K	$6M	$-4M	$32M	$18M	$7M	$13M	$0	$8M	$29M
Other Non-cash	$-25M	$-103M	$2M	$-680M	$-94M	$-300.0K	$110M	$-95M	$3M	$158M	$-144M	$-41M
Operating Cash Flow	$242M	$214M	$276M	$306M	$277M	$310M	$370M	$414M	$318M	$318M	$229M	$264M
CapEx	$43M	$45M	$31M	$21M	$19M	$34M	$64M	$109M	$49M	$52M	$40M	$44M
Investing Cash Flow	$-549M	$-318M	$-31M	$-21M	$-16M	$-229M	$-221M	$-752M	$-87M	$-51M	$-35M	$-26M
Debt Issued	·	·	·	·	$0	$0	$3M	$567M	$0	$0	$0	$0
Net Debt Issued	$0	$0	$-300M	·	$0	·	$-96M	$115M	·	·	$0	$0
Stock Repurchased	·	·	·	$204M	$96M	$70M	$80M	$50M	$25M	$0	$25M	$50M
Net Stock Activity	·	·	·	$-204M	$-96M	$-70M	$-80M	$-50M	$-25M	$0	$-25M	$-50M
Dividends Paid	$39M	$37M	$24M	$0	$0	$100M	$93M	$84M	$78M	$77M	$77M	$74M
Financing Cash Flow	$364M	$62M	$-252M	$-135M	$-298M	$55M	$-125M	$-8M	$-81M	$-100M	$-144M	$-133M
Net Change in Cash	$73M	$-54M	$-4M	$130M	$-44M	$157M	$50M	$-363M	$196M	$146M	$17M	$76M
Taxes Paid	$51M	$64M	$46M	$64M	$25M	$46M	$35M	$58M	$84M	$70M	$51M	$40M
Free Cash Flow	$198M	$169M	$245M	$-210M	$415M	$275M	$325M	$305M	$268M	$267M	$190M	$220M
Levered FCF	·	·	·	$-247M	$376M	$231M	$288M	$263M	$252M	$239M	$164M	$193M

Rentowność 8

Dane roczne Rentowność dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	·	·	·	·	39.0%	·	35.9%	35.5%	36.4%	36.0%	34.8%	34.8%
Operating Margin	14.9%	18.1%	20.6%	10.9%	15.8%	8.9%	6.4%	13.2%	14.4%	7.3%	13.6%	10.8%
Net Margin	8.8%	12.4%	13.5%	11.9%	13.7%	6.2%	4.1%	10.0%	6.2%	4.5%	8.3%	6.6%
Pretax Margin	10.9%	15.2%	17.2%	16.7%	15.0%	7.6%	5.2%	12.3%	13.2%	6.0%	12.3%	9.6%
EBITDA Margin	21.3%	23.9%	26.2%	14.5%	19.6%	13.3%	9.9%	16.8%	17.0%	9.7%	16.1%	13.4%
ROA	5.3%	8.2%	8.8%	9.0%	9.6%	4.0%	3.1%	8.8%	4.9%	3.6%	6.8%	5.5%
ROE	12.5%	17.2%	20.5%	30.8%	31.7%	12.1%	8.9%	23.4%	13.9%	10.8%	20.8%	17.0%
ROIC	14.2%	17.1%	23.2%	8.4%	15.5%	7.7%	6.7%	14.5%	9.0%	8.0%	13.2%	11.4%

Płynność i wypłacalność 5

Dane roczne Płynność i wypłacalność dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.5	1.1	1.9	1.2	2.2	1.5	1.6	1.8	1.8	2.5	2.1	1.9
Quick Ratio	1.0	0.8	1.3	0.8	1.2	0.9	1.0	1.2	1.3	1.7	1.3	1.2
Debt / Equity	0.1	0.2	0.0	0.7	0.5	0.8	0.7	0.6	0.6	0.7	0.7	0.8
LT Debt / Equity	·	·	·	0.3	0.5	0.6	0.6	0.6	0.4	0.7	0.7	0.7
Interest Coverage	·	·	·	7.1	10.7	4.8	4.5	8.7	11.1	5.5	9.9	8.1

Efektywność 3

Dane roczne Efektywność dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.6	0.7	0.7	0.8	0.7	0.7	0.8	0.9	0.8	0.8	0.8	0.8
Inventory Turnover	6.1	5.4	4.9	4.6	4.5	4.3	4.8	5.7	5.1	4.9	4.8	5.2
Receivables Turnover	5.4	6.2	6.6	7.0	7.1	5.9	6.1	7.2	6.8	6.9	6.8	6.9

Na akcję 6

Dane roczne Na akcję dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$21.81	$18.62	$16.94	$33.76	$31.68	$26.30	$24.98	$25.61	$22.64	·	·	$18.23
Revenue / Share	$28.56	$25.72	$24.20	$59.00	$53.72	$49.95	$54.18	$54.84	$46.13	$46.34	$46.61	$49.07
Cash Flow / Share	$4.16	$3.70	$4.81	$-2.65	$7.88	$5.26	$6.50	$6.78	$5.26	$5.36	$3.90	$4.43
Cash / Share	$4.07	$2.90	$3.99	$11.68	$8.28	$9.48	$6.68	$5.77	$11.89	·	·	$5.96
Dividend / Share	$1	$1	$0	$2	$2	$2	$2	$1	$1	·	·	·
EPS (TTM)	$2.50	$3.19	$3.28	$3.61	$3.14	$3.08	$2.20	$5.50	$2.84	$2.07	$3.89	$3.23

Stopy Wzrostu 10

Dane roczne Stopy Wzrostu dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	11.4%	6.9%	3.8%	-0.39%	-54.2%	·	·	·	·	·	·	·
Revenue CAGR 3Y	7.3%	3.4%	-22.1%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-10.8%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-21.6%	-2.7%	-9.1%	15.0%	1.9%	·	·	·	·	·	·	·
EPS CAGR 3Y	-11.5%	0.53%	2.1%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	-4.1%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-21.2%	-2.2%	-8.1%	15.1%	-1.7%	·	·	·	·	·	·	·
Net Income CAGR 3Y	-10.9%	1.1%	1.3%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	-4.3%	·	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	-17.2%	·	·	·	·	·	·	·	·	·	·	·

Wycena (TTM) 16

Dane roczne Wycena (TTM) dla CXT
Wskaźnik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$1.66B	$1.49B	$1.39B	$1.34B	$1.35B	$2.94B	$3.07B	$3.35B	$2.79B	$2.75B	$2.74B	$2.92B
Net Income TTM	$145M	$184M	$188M	$205M	$178M	$181M	$133M	$336M	$172M	$123M	$229M	$193M
Market Cap	$2.70B	$3.33B	$3.24B	$1.97B	$2.04B	$1.57B	$1.77B	$1.49B	$1.84B	·	·	$1.19B
Enterprise Value	$2.61B	$3.37B	$3.01B	$2.55B	$2.41B	$2.24B	$2.37B	$2.10B	$1.88B	·	·	$1.69B
P/E	18.8	18.3	17.3	9.7	11.3	8.8	13.6	4.6	10.9	12.1	4.3	6.3
P/S	1.6	2.2	2.3	1.5	1.5	0.5	0.6	0.4	0.7	·	·	0.4
P/B	2.2	3.1	3.4	1.0	1.1	1.0	1.2	1.0	1.4	·	·	1.1
P / Cash Flow	11.2	15.6	11.7	-13.0	4.4	5.1	4.5	3.6	5.8	·	·	4.5
P / FCF	13.6	19.7	13.2	-9.4	4.9	5.7	5.4	4.9	6.9	·	·	5.4
EV / EBITDA	7.4	9.5	8.3	5.2	3.9	5.7	7.3	3.7	4.0	·	·	4.3
EV / FCF	13.1	20.0	12.3	-12.1	5.8	8.1	7.3	6.9	7.0	·	·	7.7
EV / Revenue	1.6	2.3	2.2	1.9	1.8	0.8	0.8	0.6	0.7	·	·	0.6
Dividend Yield	1.4%	1.1%	0.73%	0.00%	0.00%	6.4%	5.3%	5.6%	4.3%	·	·	6.2%
Earnings Yield	5.3%	5.5%	5.8%	10.3%	8.9%	11.4%	7.3%	21.9%	9.2%	8.3%	23.4%	15.8%
Payout Ratio	26.9%	19.9%	12.6%	26.4%	23.1%	55.5%	69.9%	24.9%	45.6%	62.9%	33.5%	38.4%
Annual Payout	$39M	$37M	$24M	$0	$0	$100M	$93M	$84M	$78M	$77M	$77M	$74M

Rachunek zysków i strat 15

Dane kwartalne Rachunek zysków i strat dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$388M	$477M	$445M	$404M	$330M	$399M	$404M	$371M	$314M	$357M	$353M	$352M	$329M	$-201M	$335M	$334M
Cost of Revenue	$232M	$275M	$252M	$236M	$190M	$219M	$232M	$210M	$161M	$191M	$187M	$184M	$174M	$-170M	$175M	$183M
SG&A Expense	$131M	$117M	$107M	$114M	$103M	$102M	$96M	$93M	$94M	$93M	$86M	$100M	$89M	$-40M	$82M	$78M
Operating Income	$22M	$80M	$82M	$48M	$37M	$71M	$75M	$68M	$55M	$72M	$80M	$69M	$66M	$3M	$78M	$73M
Interest Expense	·	·	·	·	·	·	·	·	·	·	·	·	$17M	·	$14M	$11M
Interest Income	·	$300.0K	$300.0K	$200.0K	$200.0K	$200.0K	$400.0K	$400.0K	$600.0K	$400.0K	$300.0K	$200.0K	$200.0K	$-200.0K	$0	$100.0K
Other Non-op	$100.0K	$1M	$600.0K	$1M	$2M	$1M	$1M	$-200.0K	$600.0K	$-600.0K	$700.0K	$1M	$1M	$-3M	$400.0K	$2M
Pretax Income	$9M	$54M	$67M	$33M	$28M	$61M	$63M	$55M	$47M	$61M	$68M	$56M	$55M	$-17M	$64M	$62M
Income Tax	$2M	$6M	$16M	$8M	$6M	$3M	$16M	$14M	$9M	$12M	$16M	$13M	$11M	$-24M	$20M	$13M
Net Income	$6M	$48M	$50M	$25M	$22M	$58M	$47M	$42M	$38M	$50M	$52M	$43M	$44M	$62M	$45M	$49M
EPS (Basic)	$0.11	$0.84	$0.88	$0.43	$0.38	$1.01	$0.82	$0.73	$0.66	$0.87	$0.91	$0.76	$0.77	$0.12	$0.79	$0.86
EPS (Diluted)	$0.11	$0.82	$0.87	$0.43	$0.38	$1.00	$0.81	$0.72	$0.66	$0.86	$0.90	$0.75	$0.77	$0.15	$0.79	$0.86
Shares (Basic)	57,500,000	-114,700,000	57,400,000	57,400,000	57,300,000	-114,200,000	57,200,000	57,100,000	57,000,000	-113,500,000	56,800,000	56,800,000	56,700,000	-113,800,000	56,700,000	56,700,000
Shares (Diluted)	58,000,000	-115,800,000	58,000,000	57,900,000	57,900,000	-115,500,000	57,800,000	57,800,000	57,700,000	-114,100,000	57,500,000	57,400,000	56,700,000	-114,600,000	56,700,000	56,700,000
EBITDA	$52M	·	$111M	$75M	$59M	·	$75M	$68M	$74M	·	$80M	$69M	$181M	·	$-31M	$124M

Bilans 30

Dane kwartalne Bilans dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$228M	$234M	$182M	$152M	$174M	$166M	$165M	$176M	$221M	·	$229M	$277M	$510M	·	$439M	$651M
Receivables	$420M	$352M	$301M	$309M	$274M	$266M	$215M	$225M	$183M	·	$179M	$201M	$500M	·	$487M	$490M
Inventory	$260M	$170M	$196M	$190M	$158M	$145M	$170M	$171M	$166M	·	$166M	$174M	$493M	·	$436M	$443M
Other Current Assets	$91M	$85M	$82M	$75M	$63M	$57M	$62M	$55M	$60M	·	$51M	$50M	$193M	·	$121M	$131M
Current Assets	$1.01B	$853M	$771M	$743M	$677M	$642M	$631M	$632M	$629M	·	$625M	$701M	$1.70B	·	$1.48B	$1.73B
PP&E (Net)	$321M	$304M	$308M	$310M	$276M	$272M	$278M	$271M	$255M	·	$245M	$251M	$508M	·	$494M	$514M
PP&E (Gross)	$716M	$689M	$682M	$676M	$620M	$600M	$609M	$586M	$562M	·	$531M	$531M	$1.27B	·	$1.22B	$1.24B
Accum. Depreciation	$395M	$385M	$374M	$367M	$344M	$328M	$331M	$315M	$307M	·	$287M	$280M	$761M	·	$725M	$725M
Goodwill	$1.40B	$1.16B	$1.16B	$1.17B	$964M	$957M	$965M	$950M	$830M	$841M	$827M	$835M	$1.53B	$837M	$1.50B	$1.52B
Intangibles	$789M	$557M	$573M	$592M	$412M	$419M	$440M	$444M	$297M	$309M	$314M	$325M	$406M	$345M	$420M	$436M
Other Non-current Assets	$98M	$97M	$104M	$104M	$98M	$92M	$96M	$87M	$85M	·	$78M	$78M	$185M	·	$233M	$240M
Total Assets	$3.64B	$3.12B	$2.92B	$2.92B	$2.43B	$2.39B	$2.41B	$2.39B	$2.10B	·	$2.09B	$2.19B	$4.34B	·	$4.13B	$4.50B
Accounts Payable	$131M	$132M	$115M	$104M	$87M	$117M	$108M	$101M	$84M	·	$111M	$101M	$247M	·	$241M	$248M
Accrued Liabilities	$358M	$273M	$226M	$233M	$198M	$211M	$183M	$205M	$170M	·	$182M	$198M	$396M	·	$396M	$362M
Short-term Debt	$250M	$135M	$248M	$267M	$264M	$210M	$155M	$220M	$30M	·	$7M	$9M	$308M	·	$400M	$119M
Current Liabilities	$763M	$569M	$610M	$619M	$564M	$562M	$456M	$527M	$297M	·	$313M	$317M	$974M	·	$1.08B	$845M
Capital Leases	·	$56M	·	·	·	$53M	·	·	·	·	·	·	·	·	·	·
Deferred Tax	$212M	$151M	$150M	$154M	$118M	$119M	$131M	$132M	$104M	·	$112M	$105M	$161M	·	$166M	$75M
Other Non-current Liabilities	$120M	$116M	$90M	$85M	$80M	$80M	$92M	$78M	$73M	·	$68M	$68M	$148M	·	$145M	$143M
Total Liabilities	$2.38B	$1.86B	$1.71B	$1.74B	$1.32B	$1.32B	$1.34B	$1.40B	$1.13B	·	$1.22B	$1.34B	$2.32B	·	$2.42B	$2.63B
Long-term Debt	$1.26B	$1.00B	$834M	$862M	$541M	$541M	$638M	$639M	$640M	·	$708M	$830M	·	·	·	·
Total Debt	$250M	·	$248M	$267M	$264M	·	$155M	$220M	$30M	·	$7M	$9M	$1.19B	·	$1.24B	$962M
Common Stock	$72M	$72M	$72M	$72M	$72M	$72M	$72M	$72M	$72M	·	$72M	$72M	$72M	·	$72M	$72M
Paid-in Capital	$1.71B	$1.72B	$1.72B	$1.71B	$1.71B	$1.72B	$1.72B	$1.72B	$1.72B	·	$1.72B	$1.72B	$377M	·	$368M	$369M
Retained Earnings	$371M	$374M	$336M	$296M	$280M	$268M	$220M	$182M	$150M	·	$79M	$35M	$2.90B	·	$2.75B	$2.84B
Treasury Stock	$802M	$810M	$812M	$814M	$815M	$823M	$824M	$827M	$828M	·	$844M	$844M	$848M	·	$878M	$887M
AOCI	$-111M	$-100M	$-98M	$-92M	$-142M	$-173M	$-116M	$-155M	$-146M	·	$-152M	$-131M	$-488M	·	$-606M	$-531M
Stockholders' Equity	$1.24B	$1.25B	$1.21B	$1.17B	$1.11B	$1.06B	$1.07B	$990M	$964M	·	$873M	$855M	$2.02B	$784M	$1.71B	$1.86B
Liabilities + Equity	$3.64B	$3.12B	$2.92B	$2.92B	$2.43B	$2.39B	$2.41B	$2.39B	$2.10B	·	$2.09B	$2.19B	$4.34B	·	$4.13B	$4.50B
Shares Outstanding	57,537,288	57,441,541	57,422,039	57,387,420	57,357,459	57,197,147	57,178,212	57,135,553	57,115,678	·	56,803,152	56,794,268	56,725,307	·	56,136,580	56,092,755

Przepływy pieniężne 14

Dane kwartalne Przepływy pieniężne dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$30M	$29M	$29M	$27M	$22M	$23M	$25M	$20M	$18M	$19M	$20M	$10M	$19M	$19M	$-2M	$11M
Stock-based Comp	$15M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$-2M	$2M	$2M	$-5M	$-1M
Deferred Tax	$-2M	$-3M	$1M	$-12M	$-500.0K	$-15M	$-500.0K	$0	$200.0K	$-7M	$0	$5M	$3M	$-41M	$-7M	$8M
Amort. of Intangibles	$16M	$16M	$16M	$16M	$11M	$13M	$14M	$11M	$9M	$9M	$9M	$8M	$10M	$5M	$10M	$10M
Restructuring	$3M	$6M	$4M	$7M	$0	$7M	$0	$0	$3M	$500.0K	$0	$0	$0	$6M	$0	$0
Other Non-cash	$-114M	·	·	·	$-126M	·	·	·	$-100M	·	·	·	$-426M	·	·	·
Operating Cash Flow	$-14M	$106M	$92M	$63M	$-19M	$81M	$67M	$57M	$10M	$78M	$103M	$166M	$36M	$75M	$182M	$170M
Investing Cash Flow	$-231M	$-126M	$-10M	$-399M	$-14M	$-14M	$-13M	$-279M	$-12M	$-15M	$-8M	$4M	$-4M	$-9M	$-301M	$5M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	·	·	$0	·	$0	$28M
Net Stock Activity	·	·	·	·	·	·	·	·	·	·	·	·	$0	·	·	·
Dividends Paid	$10M	$10M	$10M	$10M	$10M	$9M	$9M	$9M	$9M	$8M	$8M	$-19M	$0	$0	$-53M	$-27M
Financing Cash Flow	$240M	$70M	$-52M	$307M	$38M	$-54M	$-74M	$180M	$11M	$-76M	$-133M	$24M	$-47M	$-46M	$47M	$25M
Net Change in Cash	$-7M	$51M	$30M	$-21M	$12M	$-600.0K	$-9M	$-44M	$-300.0K	$-2M	$-48M	$194M	$-12M	$34M	$-77M	$199M
Taxes Paid	$11M	$3M	$6M	$26M	$16M	$2M	$20M	$33M	$9M	$8M	$9M	$-13M	$6M	$15M	$-27M	$5M

Rentowność 7

Dane kwartalne Rentowność dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	5.7%	·	18.4%	11.8%	11.3%	·	18.6%	18.2%	17.7%	·	22.6%	19.5%	18.1%	·	-3.8%	14.4%
Net Margin	1.7%	·	11.3%	6.2%	6.6%	·	11.7%	11.2%	12.0%	·	14.7%	12.3%	12.5%	·	-7.3%	29.9%
Pretax Margin	2.4%	·	15.0%	8.1%	8.5%	·	15.7%	14.9%	14.9%	·	19.2%	15.9%	15.9%	·	-4.3%	41.3%
EBITDA Margin	13.4%	·	24.9%	18.6%	17.8%	·	18.6%	18.2%	23.6%	·	22.6%	19.5%	21.4%	·	-3.8%	14.4%
ROA	0.21%	·	1.9%	0.94%	0.96%	·	2.1%	1.8%	1.2%	·	1.7%	1.3%	2.4%	·	-1.4%	5.8%
ROE	0.55%	·	4.4%	2.3%	2.1%	·	4.9%	4.5%	2.5%	·	4.0%	3.2%	5.7%	·	-3.4%	14.4%
ROIC	1.1%	·	4.3%	2.5%	2.1%	·	4.5%	4.2%	4.5%	·	6.9%	6.2%	3.8%	·	-1.8%	3.2%

Płynność i wypłacalność 5

Dane kwartalne Płynność i wypłacalność dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.3	·	1.3	1.2	1.2	·	1.4	1.2	2.1	·	2.0	2.2	1.7	·	1.4	2.0
Quick Ratio	0.8	·	0.8	0.7	0.8	·	0.8	0.8	1.4	·	1.3	1.5	1.0	·	0.9	1.3
Debt / Equity	0.2	·	0.2	0.2	0.2	·	0.1	0.2	0.0	·	0.0	0.0	0.6	·	0.7	0.5
LT Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	0.4	·	0.5	0.5
Interest Coverage	·	·	·	·	·	·	·	·	·	·	·	·	9.0	·	-2.3	10.9

Efektywność 3

Dane kwartalne Efektywność dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.1	·	0.2	0.2	0.1	·	0.2	0.2	0.1	·	0.1	0.1	0.2	·	0.2	0.2
Inventory Turnover	1.1	·	1.4	1.3	1.2	·	1.4	1.2	0.5	·	0.6	0.6	1.0	·	1.1	1.2
Receivables Turnover	1.1	·	1.7	1.5	1.4	·	2.0	1.7	0.9	·	1.1	1.0	1.7	·	1.6	1.8

Na akcję 7

Dane kwartalne Na akcję dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$21.54	·	$21.14	$20.47	$19.29	·	$18.73	$17.32	$16.88	·	$15.36	$15.06	$35.53	·	$30.43	$33.19
Revenue / Share	$6.68	·	$7.67	$6.98	$5.70	·	$6.98	$6.41	$5.43	·	$6.14	$6.14	$14.71	·	$14.53	$15.19
Cash Flow / Share	$-0.24	·	·	·	$-0.33	·	·	·	$0.16	·	·	·	$-1.24	·	·	·
Cash / Share	$3.97	·	$3.18	$2.66	$3.03	·	$2.89	$3.07	$3.86	·	$4.03	$4.88	$8.99	·	$7.81	$11.60
Dividend / Share	$0	$0	$0	$0	$0	$0	$0	$0	$0	$-0	$0	$0	$0	·	$0	$0
Dividend Paid / Share	·	·	·	·	·	·	$0	·	·	·	$0	·	·	·	·	·
EPS (TTM)	$1.79	·	$2.49	$2.34	$2.57	·	$3.09	$3.03	$3.08	·	$3.21	$3.17	$4.23	·	$4.68	$5.85

Wycena (TTM) 13

Dane kwartalne Wycena (TTM) dla CXT
Wskaźnik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$1.57B	·	$1.58B	$1.51B	$1.42B	·	$1.44B	$1.39B	$1.35B	·	$1.37B	$1.35B	$1.87B	·	$2.31B	$2.87B
Net Income TTM	$104M	·	$144M	$135M	$148M	·	$178M	$174M	$177M	·	$183M	$180M	$187M	·	$215M	$287M
Market Cap	$2.34B	·	$3.85B	$3.09B	$2.95B	·	$3.21B	$3.51B	$3.54B	·	$3.16B	$3.21B	$2.24B	·	$1.71B	$1.71B
Enterprise Value	$2.36B	·	$3.92B	$3.21B	$3.04B	·	$3.20B	$3.55B	$3.35B	·	$2.93B	$2.94B	$2.92B	·	$2.51B	$2.02B
P/E	22.7	·	26.9	23.0	20.0	·	18.2	20.3	20.1	·	17.3	17.8	9.3	·	6.5	5.2
P/S	1.5	·	2.4	2.1	2.1	·	2.2	2.5	2.6	·	2.3	2.4	1.2	·	0.7	0.6
P/B	1.9	·	3.2	2.6	2.7	·	3.0	3.5	3.7	·	3.6	3.7	1.1	·	1.0	0.9
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	·	28.7	·	·	·
P / Cash Flow	-166.8	·	·	·	-154.4	·	·	·	372.2	·	·	·	-31.6	·	·	·
EV / EBITDA	45.4	·	35.3	42.8	51.6	·	42.6	52.6	45.3	·	36.8	42.7	16.1	·	-80.5	16.2
EV / Revenue	1.5	·	2.5	2.1	2.1	·	2.2	2.6	2.5	·	2.1	2.2	1.6	·	1.1	0.7
Earnings Yield	4.4%	·	3.7%	4.3%	5.0%	·	5.5%	4.9%	5.0%	·	5.8%	5.6%	10.7%	·	15.4%	19.2%
Payout Ratio	160.9%	·	·	·	44.7%	·	·	·	24.1%	·	·	·	25.2%	·	·	·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Przychody	$1.66B	$1.49B	$1.39B	$1.34B	$1.35B
Marża Brutto %	—	—	—	—	39.0%
Marża Operacyjna %	14.9%	18.1%	20.6%	10.9%	15.8%
Zysk netto	$145M	$184M	$188M	$205M	$178M
Rozwodniony EPS	$2.50	$3.19	$3.28	$3.61	$3.14

Bilans

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dług / Kapitał Własny	0.1	0.2	0.0	0.7	0.5
Wskaźnik bieżący	1.5	1.1	1.9	1.2	2.2
Wskaźnik Szybkości	1.0	0.8	1.3	0.8	1.2

Przepływy pieniężne

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Wolny przepływ pieniężny	$198M	$169M	$245M	$-210M	$415M

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

CXT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

CXT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Średnie ruchome i nakładki

Wolumen

Oscylatory

Momentum i trend

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

CXT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

12-miesięczny cel cenowy

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów